Search all trials

Find therapies in clinical trials near you – page 27

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Primary immunodeficiency syndrome

Not recruiting

Registered drugNo placebo

Study on the Effects of TAK-881 and Hyaluronidase in Adults with Primary Immunodeficiency Diseases

Registered drugNo placebo

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Human Normal Immunoglobulin

Contact Research Centre

Dermatitis atopic

Not recruiting

InvestigationalNo placebo

Study on the Long-Term Safety and Efficacy of Nemolizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

InvestigationalNo placebo

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Nemolizumab

Contact Research Centre

Neurodermatitis

Not recruiting

InvestigationalNo placebo

Study on the Long-Term Safety and Effectiveness of Nemolizumab for Patients with Prurigo Nodularis

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Nemolizumab

Contact Research Centre

Colitis ulcerative+1

Not recruiting

InvestigationalNo placebo

Study on the Long-Term Effects of TEV-48574 (Duvakitug) for Adults with Moderate to Severe Ulcerative Colitis or Crohn's Disease

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Duvakitug

Contact Research Centre

Ovarian cancer

Not recruiting

Registered drug

Study on the Effectiveness of Durvalumab, Olaparib, and Bevacizumab in Patients with Newly Diagnosed Advanced Ovarian Cancer

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Chronic spontaneous urticaria

Not recruiting

Registered drug

Study on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Barzolvolimab

Contact Research Centre

Gastric cancer+1

Not recruiting

Registered drug

Study on Durvalumab and FLOT Chemotherapy for Patients with Resectable Gastric and Gastroesophageal Cancer

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Docetaxel

Contact Research Centre

Primary immunodeficiency syndrome

Not recruiting

InvestigationalNo placebo

Study on Long-term Safety of TAK-881 (Human Normal Immunoglobulin, Hyaluronidase) for Patients with Primary Immunodeficiency Diseases

InvestigationalNo placebo

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Human Normal Immunoglobulin

Contact Research Centre

Dermatomyositis

Not recruiting

Registered drug

Study on the Effects of Human Normal Immunoglobulin in Adults with Dermatomyositis

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Human Normal Immunoglobulin

Contact Research Centre

Systemic lupus erythematosus

Not recruiting

InvestigationalNo placebo

Study of Anifrolumab for Adults with Moderate-to-Severe Systemic Lupus Erythematosus

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Anifrolumab

Contact Research Centre

Psoriasis

Not recruiting

Investigational

Study on the Effects of JNJ-81241459 for Patients with Moderate to Severe Psoriasis

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Jnj-81241459

Contact Research Centre

Colitis ulcerative+1

Not recruiting

Investigational

Study on the Effects of TEV-48574 for Adults with Moderate to Severe Ulcerative Colitis or Crohn's Disease

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Duvakitug

Contact Research Centre

Find therapies in clinical trials near you – page 27

605 trials match your criteria

Primary immunodeficiency syndrome

Study on the Effects of TAK-881 and Hyaluronidase in Adults with Primary Immunodeficiency Diseases

Dermatitis atopic

Study on the Long-Term Safety and Efficacy of Nemolizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

Neurodermatitis

Study on the Long-Term Safety and Effectiveness of Nemolizumab for Patients with Prurigo Nodularis

Colitis ulcerative+1

Study on the Long-Term Effects of TEV-48574 (Duvakitug) for Adults with Moderate to Severe Ulcerative Colitis or Crohn's Disease

Ovarian cancer

Study on the Effectiveness of Durvalumab, Olaparib, and Bevacizumab in Patients with Newly Diagnosed Advanced Ovarian Cancer

Chronic spontaneous urticaria

Study on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines

Gastric cancer+1

Study on Durvalumab and FLOT Chemotherapy for Patients with Resectable Gastric and Gastroesophageal Cancer

Primary immunodeficiency syndrome

Study on Long-term Safety of TAK-881 (Human Normal Immunoglobulin, Hyaluronidase) for Patients with Primary Immunodeficiency Diseases

Dermatomyositis

Study on the Effects of Human Normal Immunoglobulin in Adults with Dermatomyositis

Systemic lupus erythematosus

Study of Anifrolumab for Adults with Moderate-to-Severe Systemic Lupus Erythematosus

Psoriasis

Study on the Effects of JNJ-81241459 for Patients with Moderate to Severe Psoriasis

Colitis ulcerative+1

Study on the Effects of TEV-48574 for Adults with Moderate to Severe Ulcerative Colitis or Crohn's Disease

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.